NCT03669172View on ClinicalTrials.gov

Efectiveness of Donor IL-15-stimulated NK Cells Post Transplant Infusion in in Acute Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 2, 2017

Primary Completion Date

July 6, 2021

Study Completion Date

July 6, 2021

Conditions
ACUTE LEUKEMIA
Interventions
BIOLOGICAL

Donor IL-15 stimulated NK cells infusion

DONOR IL-15-STIMULATED NK CELLS POST TRANSPLANT INFUSION, IN ACUTE LEUKEMIA PATIENTS WITH POOR PROGNOSIS AND HAPLOIDENTICAL UNMANIPULATED TRANSPLANT

Trial Locations (1)

28007

Hospital General Universitario Gregorio Marañón, Madrid

All Listed Sponsors
lead

Martín, José Luis Díez, M.D.

INDIV

NCT03669172 - Efectiveness of Donor IL-15-stimulated NK Cells Post Transplant Infusion in in Acute Leukemia | Biotech Hunter | Biotech Hunter